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Burkholderia pseudomallei is a bacterium endemic 
to Southeast Asia and northern Australia, but it has not 
been found to occur endemically in the United States. We 
report an ostensibly autochthonous case of melioidosis in 
the United States. Despite an extensive investigation, the 
source of exposure was not identiﬁ  ed.
B
urkholderia  pseudomallei is endemic to Southeast 
Asia and northern Australia; the organism has also 
been identiﬁ   ed on other continents and islands but not 
North America (1).  B. pseudomallei is present in soil 
and water and can cause infection through inhalation, 
aspiration, ingestion, or percutaneous inoculation (2–4). 
Persons with certain chronic health conditions, particularly 
diabetes, are predisposed to melioidosis disease after 
exposure to this bacterium. Person-to-person transmission 
has been documented but is rare (5). Clinical signs of the 
disease vary, depending in part on the route of exposure, 
and can manifest as pneumonia, septicemia, or single or 
multiple abscesses (2). Treatment is prolonged and made 
more difﬁ   cult by the bacterium’s intrinsic resistance to 
antimicrobial drugs (6). No cases of B. pseudomallei 
infection have been documented in the United States in 
persons without a history of prior travel to a country where 
the disease is endemic (7).
The Study
In October 2008, a 32-year-old man with a history of 
type II diabetes, hypertension, and obesity was admitted 
to a small community hospital (hospital A) in Arizona. 
He had severe right knee pain and fever. On 3 occasions 
the week before being admitted, he had been evaluated in 
hospital A’s emergency department for severe right knee 
pain. The patient denied cough, chest pain, and swelling 
and pain of other joints. Over the course of 2–3 months, 
he lost weight and had exhaustion, intermittent right knee 
pain, and nightly fevers. The patient denied recent trauma.
Medications at admission included those common 
for control of diabetes. The patient did not smoke, drink 
alcohol, or use illicit drugs and was in a monogamous 
heterosexual relationship. He worked at an automobile 
body shop preparing and painting cars and had previously 
worked as a motorcycle and all-terrain vehicle mechanic. 
He reported gardening as a hobby and had many indoor and 
outdoor plants. He also had several dogs in the household 
but reported no unusual exposure to other animals.
After admission to hospital A, the patient underwent 
arthrocentesis of the right knee. Culture of the synovial 
ﬂ  uid did not yield any bacterial growth, and evidence of 
infection or crystals was not apparent. A blood specimen 
was sent for culture and yielded what was initially identiﬁ  ed 
as Escherichia coli by an automated in-house instrument. 
Sensitivity to antimicrobial drugs was consistent with this 
bacterium.
Chest radiograph and computerized axial tomo-
graphy scan with contrast were unremarkable and did 
not demonstrate evidence of pneumonia. Laboratory 
tests indicated no sexually transmitted infections. The 
patient received clindamycin, imipenem, vancomycin, 
and metronidazole intravenously. After 8 days in 
hospital A and no resolution of fever or knee pain, he 
was transferred to hospital B, a large regional hospital, 
with an initial diagnosis of persistent E. coli sepsis and 
possible vegetative valve lesions. Transesophageal 
echocardiogram performed at hospital B did not show 
vegetative valve lesions.
After admission to hospital B, the patient underwent 
arthrocentesis of the right knee. Although there was 
evidence of infection, synovial ﬂ  uid culture yielded no 
growth. Blood cultures grew B. pseudomallei identiﬁ  ed 
by an automated in-house instrument. Because initial 
results were unexpected, blood samples were submitted 
to a reference laboratory and the Arizona State Public 
Health Laboratory (Phoenix, AZ, USA) where results 
conﬁ  rmed the presence of B. pseudomallei. The bacteria 
continued to grow in blood cultures for 16 days after 
initial hospitalization at hospital A on October 7. Cultures 
of the knee ﬂ  uid grew B. pseudomallei for 7 days; sputum 
cultures were positive for 6 days. All cultures were 
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negative 2 weeks before the patient was discharged from 
hospital B on December 5.
The patient’s hospital course was complicated by 
respiratory failure that required intubation and ventilation, 
acute renal failure, pneumothorax and pneumoperitoneum, 
and anemia and hypotension. Fever resolved 21 days after 
admission to hospital A. Knee swelling persisted for ≈6 
weeks. Antimicrobial therapy administered to the patient 
while he was an inpatient in hospital B included meropenem, 
moxiﬂ   oxacin, vancomycin, ceftazidime, gentamicin, and 
trimethoprim/sulfamethoxazole. The patient was discharged 
with oral doxycycline and trimethoprim/sulfamethoxazole 
to a rehabilitation facility 7 weeks after his initial hospital 
admission.
Clinical isolates were analyzed to conﬁ  rm  B. 
pseudomallei infection and to determine the genetic 
origin of the isolate strain. Specimens from hospital A had 
been destroyed by the time the patient’s melioidosis was 
diagnosed, which precluded the possibility of determining 
whether the presumptive E. coli infection was actual or 
misdiagnosed. After receipt at the Arizona State Public 
Health Laboratory, an isolate was submitted to the Centers 
for Disease Control and Prevention (Atlanta, GA, USA) for 
conﬁ  rmation, and bacterial DNA was extracted and sent to 
the Translational Genomics Research Institute (Phoenix, 
AZ, USA) for genetic characterization. Molecular analyses 
determined that the isolate strain originated from Southeast 
Asia, most likely Malaysia, or a nearby country. Serologic 
testing performed 6 weeks post infection demonstrated a 
B. pseudomallei indirect hemagglutination assay titer of 
160; any titer is considered positive in a person living in an 
area where the disease is nonendemic (2). Serum samples 
collected early in the course of illness were not available 
for testing.
The patient and his family were interviewed to 
determine travel history and possible sources of exposure. 
No lifetime travel outside of the United States and only 
limited intrastate and interstate travel were established. 
The epidemiologic investigation, therefore, focused on the 
patient’s home and work sites. Possibilities for exposure 
included occupational exposure to imported vehicle parts, 
exposure to a person or object from a disease-endemic 
area, recreational exposure to imported soil or plants, or 
inoculation with contaminated medication.
Extensive investigation showed no evidence of 
exposure at the patient’s worksite and no known exposure 
to any person or objects from a disease-endemic area. 
We conducted multiple on-site residential investigations, 
primarily focusing on the patient’s self-reported history 
of exotic plant repotting. Plant soil and root samples were 
collected in and around the patient’s home 6 weeks after 
diagnosis (winter), and 6 months later (summer) and were 
taken for analysis to the select agent laboratory of Northern 
Arizona University (Flagstaff, AZ, USA). B. pseudomallei 
could not be cultured from any of the samples tested.
Infection may have occurred from exposure to 
contaminated medical products. Because the patient was 
initially hospitalized with sepsis identiﬁ  ed as E. coli, sepsis 
might have been the source of his knee pain, and he was 
subsequently inoculated with B. pseudomallei during knee 
arthrocentesis or from a contaminated oral or intravenous 
medication. However, investigation of possible medication 
contamination did not yield any remarkable results.
Conclusions
Despite extensive investigation, when, how, or where 
the patient was exposed to B. pseudomallei remains 
unclear. Although travel to a disease-endemic area 
including Southeast Asia was ruled out, molecular analysis 
of the etiologic agent showed that it was consistent with 
Southeast Asian origin.
This case demonstrates the difﬁ   culty in diagnosing 
a disease caused by a rare organism not endemic to the 
area and the complications that can ensue from delayed 
diagnosis. Unfortunately, we could not identify the 
source of exposure despite an aggressive epidemiologic, 
environmental, and laboratory investigation. Heightened 
awareness and surveillance by public health ofﬁ  cials 
for this select agent is critical to learning more about the 
possible presence of B. pseudomallei in the United States.
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